iS Clinical Launches New Eye Gel Highlighting Multimodal Periocular Care

Key Takeaways

• A new periocular gel from iS Clinical incorporates dual forms of vitamin C, peptides, and hyaluronic acid derivatives.
• The formulation reflects a broader trend toward multimodal topical approaches for the eye area.
• The product targets common periocular concerns such as laxity, uneven tone, and dehydration.

A new topical formulation targeting the periocular region is entering the aesthetics market, with iS Clinical announcing the launch of GeneXC Firming Eye Gel. The product is designed to address common concerns such as laxity, uneven tone, and dehydration in the delicate eye area.

The formulation includes a proprietary blend featuring 2 forms of vitamin C, an ingredient widely studied for its antioxidant properties and role in supporting collagen synthesis. Additional components include hyaluronic acid derivatives to enhance hydration and peptides commonly used to target skin firmness and elasticity. Bio-fermented ingredients are also included, reflecting growing interest in fermentation-derived actives in skincare.

The periocular region presents distinct challenges due to its thinner dermis and increased susceptibility to transepidermal water loss, often necessitating combination approaches that support barrier function and reduce oxidative stress.

The product is available now at https://www.isclinical.com.